Heralding a New Era of Episodic, Chronic and Refractory Migraine Management

Symposium

Scientific Summary

Includes presentation and video highlights from the expert faculty. Try the quiz at the end of the report!

Chaired by Paolo Martelletti, with Lars Edvinsson and Messoud Ashina
12th European Headache Federation Congress Springer Healthcare IME Symposium
Held on Friday 28th September, 2018, at Palazzo dei Congressi, Florence, Italy

Watch Now: Faculty Interviews

Welcome and introduction

Paolo Martelletti

Advances in the pathophysiology of migraine

Lars Edvinssson

New therapeutic options for episodic migraine

Messoud Ashina

Management of the chronic/refractory patient

Paolo Martelletti

  • 14:00 Welcome and introduction
    Paolo Martelletti
  • 14:05 Advances in the pathophysiology of migraine
    Lars Edvinsson
  • 14:20 New therapeutic options for episodic migraine
    Messoud Ashina
  • 14:35 Management of the chronic/refractory patient
    Paolo Martelletti
  • 14:50 Faculty discussion and audience questions

The Heralding a new era of episodic, chronic and refractory migraine management, Florence, Italy, 28/09/2019-28/09/2019 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

This programme is made possible thanks to independent educational sponsorship from Eli Lilly and Company.